|
|
|
Background
The Human Genome
Project (HGP) is an international research coalition, funded by the National
Institute of Health, the Department of Energy, and the private firm, Celera
Genomics. The goals of the HGP are to determine the complete nucleotide
sequence of human DNA and other important model research organisms, commonly
used to understand genetic mechanisms, including the mouse, the fruit
fly Drosophila melanogaster, the bacterium Escherichia coli,
and the zebra fish Danio rerio. James Watson and Francis Crick's
discovery of the double helical structure of DNA in 1957 represents the
HGP's informal inception. The culmination of the HGP occurred in February
2001 with the publication of the first draft sequence in Science
and Nature magazines. Many believe the genetic technologies emerging
in the wake of the HGP will transform all domains of medicine, including
our understanding of the sources of illness, disease prevention, diagnostics
treatment, and the development of targeted drugs. Many have also identified
certain challenges to justice that may come into focus as a result of
the HGP. Which populations will have access to genetic technologies? Do
individuals have a right to privacy with respect to sharing genetic information?
Is it ethical to alter human gene sequences? These topics have been addressed
elsewhere. Here, I will discuss the implications of the HGP in terms of
another challenge to justice: the glaring disparities in health between
certain racialized segments of the U.S. population (see 'selected topics').
This
page created by Margaret Seater
|
|